Download - Brugts JJ, et al. BMJ 2009;338:b2376
Transcript
![Page 1: Brugts JJ, et al. BMJ 2009;338:b2376](https://reader035.vdocuments.us/reader035/viewer/2022072117/568139d6550346895da18a87/html5/thumbnails/1.jpg)
Brugts JJ, et al. BMJ 2009;338:b2376
![Page 2: Brugts JJ, et al. BMJ 2009;338:b2376](https://reader035.vdocuments.us/reader035/viewer/2022072117/568139d6550346895da18a87/html5/thumbnails/2.jpg)
Flow of article selection in trial
Brugts JJ, et al. BMJ 2009;338:b2376
![Page 3: Brugts JJ, et al. BMJ 2009;338:b2376](https://reader035.vdocuments.us/reader035/viewer/2022072117/568139d6550346895da18a87/html5/thumbnails/3.jpg)
Characteristics of included trials
Bru
gts
JJ,
et
al.
BM
J 20
09;3
38:b
2376
![Page 4: Brugts JJ, et al. BMJ 2009;338:b2376](https://reader035.vdocuments.us/reader035/viewer/2022072117/568139d6550346895da18a87/html5/thumbnails/4.jpg)
Odds ratios (95% confidence intervals) for all cause mortality, major coronary events, major cerebrovascular events, and incidence of cancer
Bru
gts
JJ,
et
al.
BM
J 20
09;3
38:b
2376
![Page 5: Brugts JJ, et al. BMJ 2009;338:b2376](https://reader035.vdocuments.us/reader035/viewer/2022072117/568139d6550346895da18a87/html5/thumbnails/5.jpg)
Treatment effects of statin therapy Values are odds ratios (95% confidence intervals)
Brugts JJ, et al. BMJ 2009;338:b2376
![Page 6: Brugts JJ, et al. BMJ 2009;338:b2376](https://reader035.vdocuments.us/reader035/viewer/2022072117/568139d6550346895da18a87/html5/thumbnails/6.jpg)
Odds ratios (95% confidence intervals) for clinically definedsubgroups of sex, age, and diabetes for end points of all cause mortality,
major coronary events, major cerebrovascular events, and cancer
Bru
gts
JJ,
et
al.
BM
J 20
09;3
38:b
2376